Hill-Rom Hlds

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

We believe that Hill-Rom Holdings stock (NYSE: HRC), best known for its hospital beds and patient mobility solutions, may be a good buying opportunity at the present time. HRC stock trades near $97 currently and it is, in fact, down 15% so far this year (from $114 at the beginning of 2020).

Hill-Rom Can Offer 15% Upside

Hill-Rom Holdings has enjoyed a strong 2H 2020, with sequential growth across quarters, and a mild recovery from Covid-related headwinds. Moderate stability in bed demand, strength in international markets, and penetration in emerging markets have driven top-line growth in Q4.

Hill-Rom: Deep Value Proposition At A 30% Discount To Peers

CHICAGO, Nov. 17, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Tuesday, December 1, 2020. John Groetelaars, Hillrom's president and chief executive officer, will participate in a fireside chat...

Hillrom to Present at the 3rd Annual Evercore ISI HealthCONx Virtual Conference

In Q3, Hill-Rom's (HRC) bed orders and backlog in the United States accelerates with sequential recovery in Patient Support Systems arm.

Hill-Rom (HRC) Q4 Earnings, Revenues Top Estimates, Fall Y/Y

Hill-Rom Holdings, Inc. (HRC) CEO John Groetelaars on Q4 2020 Results - Earnings Call Transcript

Hill-Rom (HRC) delivered earnings and revenue surprises of 8.33% and 1.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Hill-Rom (HRC) Q4 Earnings and Revenues Top Estimates

CHICAGO, Nov. 6, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full year ended September 30, 2020, and provided financial guidance for fiscal 2021. For fiscal 2020, Hillrom reported GAAP earnings of $3.32 per diluted share...

Hillrom Reports Fiscal Fourth Quarter and Full-Year 2020 Financial Results

HMS Hlds

Zimmer Biomet Hlds

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how ZBH, HRC and HMS are poised ahead of their announcements.

Medical Products Stock Earnings on Nov 6: ZBH, HRC and HMSY

Hill-Rom (HRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Hill-Rom (HRC) to Report a Decline in Earnings: What to Look Out for

Hill-Rom Holdings stock gained around 10% over the month to levels of around $90 currently. But will the company's stock see higher prices over the coming weeks, or is a decline in the stock imminent?

Hill-Rom Stock Is Up 10% In A Month, Can It Move Higher?

CHICAGO, Oct. 8, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal fourth quarter 2020 earnings conference call and webcast on Friday, November 6, 2020, beginning at 7:00 a.m. (CT) / 8:00 a.m. (ET). Conference Call Audio Only Dial-in Information: To participate in the...

Hillrom To Host Fiscal Fourth Quarter 2020 Earnings Conference Call And Webcast

Investors continue to be optimistic about Hill-Rom (HRC) on product launches as well as solid third-quarter of fiscal 2020 results.

Here's Why You Should Hold on to Hill-Rom (HRC) Stock for Now

Hillrom got a boost from COVID-19-driven demand for beds and monitoring equipment, but that tailwind has faded and now the company is more exposed to near-term capex weakness.

COVID-19 Creating Near-Term Turbulence For Hillrom, But The Transformation Is Intact

CHICAGO, Sept. 1, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the virtual 18th Annual Morgan Stanley Global Healthcare Conference on Monday, September 14, 2020 via webcast.

Hillrom to Present at the Virtual 18th Annual Morgan Stanley Global Healthcare Conference

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

Why Is Hill-Rom (HRC) Down 19.5% Since Last Earnings Report?

Humana

Korn/Ferry Int.

TriMas

United States Cellular

Investors have their eyes on the pandemic stimulus this week as congress deliberates. The U.S. jobs report is expected on Friday for July and is another indicator that will be watched closely.

Top Stocks To Buy Today As Markets Trade Flat Amid Stimulus Uncertainty

Hill-Rom (HRC) benefits from increased demand for critical care products due to the coronavirus outbreak.

Hill-Rom's (HRC) Q3 Earnings Top Estimates, Margins Expand

Hill-Rom Holdings' (HRC) CEO John Groetelaars on Q3 2020 Results - Earnings Call Transcript

Hill-Rom (HRC) delivered earnings and revenue surprises of 35.42% and 3.97%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Hill-Rom (HRC) Q3 Earnings and Revenues Beat Estimates

CHICAGO, July 31, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal third quarter ended June 30, 2020 and provided commentary on current business trends and outlook. For the fiscal third quarter, Hillrom reported earnings of $1.40 per diluted share.

Hillrom Reports Strong Third Quarter Financial Results

Hill-Rom Holdings (NYSE: HRC) announces its next round of earnings this Friday, July 31.

A Preview Of Hill-Rom Holdings's Earnings

Hill-Rom (HRC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Hill-Rom (HRC)

Hill-Rom (HRC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Hill-Rom (HRC) Earnings Expected to Grow: Should You Buy?

Abbott Labs

Baxter

Boston Scientific

Intuitive Surgical

Medtronic

Perrigo

ResMed

Stryker

Medical Products Industry's Near-Term Outlook Lacks Spark

CHICAGO, June 16, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced the launch of the Hillrom™ Extended Care Solution, a new, connected remote vital signs monitoring device that allows clinicians to shift care closer to home. To ensure caregiver access to data-driven information,...

News for Hill-Rom Hlds Stock (HRC)